Urovysion™ testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer

Purpose: In this study, we investigated the ability of UroVysion™ to assess response to intravesical therapy in patients with high risk superficial bladder tumors. Materials and methods: We performed a retrospective review of patients undergoing intravesical therapy for high risk superfici...

Full description

Bibliographic Details
Main Authors: Jared M. Whitson, Anna B. Berry, Peter R. Carroll, Badrinath R. Konety
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2009-12-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382009000600005